- Home
- CBSH vs EXAS Comparison
CBSH vs EXAS Comparison
Compare CBSH & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBSH
- EXAS
- Stock Information
- Founded
- CBSH 1865
- EXAS 1995
- Country
- CBSH United States
- EXAS United States
- Employees
- CBSH N/A
- EXAS N/A
- Industry
- CBSH Major Banks
- EXAS Medical Specialities
- Sector
- CBSH Finance
- EXAS Health Care
- Exchange
- CBSH Nasdaq
- EXAS Nasdaq
- Market Cap
- CBSH 8.0B
- EXAS 10.5B
- IPO Year
- CBSH N/A
- EXAS N/A
- Fundamental
- Price
- CBSH $63.46
- EXAS $54.20
- Analyst Decision
- CBSH Hold
- EXAS Strong Buy
- Analyst Count
- CBSH 6
- EXAS 16
- Target Price
- CBSH $62.74
- EXAS $72.80
- AVG Volume (30 Days)
- CBSH 489.2K
- EXAS 1.7M
- Earning Date
- CBSH 01-22-2025
- EXAS 02-19-2025
- Dividend Yield
- CBSH 0.71%
- EXAS N/A
- EPS Growth
- CBSH 1.15
- EXAS N/A
- EPS
- CBSH 3.66
- EXAS N/A
- Revenue
- CBSH $1,616,189,000.00
- EXAS $2,692,328,000.00
- Revenue This Year
- CBSH N/A
- EXAS $11.81
- Revenue Next Year
- CBSH $1.06
- EXAS $11.52
- P/E Ratio
- CBSH $17.32
- EXAS N/A
- Revenue Growth
- CBSH 4.99
- EXAS 11.91
- 52 Week Low
- CBSH $47.09
- EXAS $40.62
- 52 Week High
- CBSH $72.75
- EXAS $79.62
- Technical
- Relative Strength Index (RSI)
- CBSH 47.72
- EXAS 38.01
- Support Level
- CBSH $60.41
- EXAS $54.74
- Resistance Level
- CBSH $63.99
- EXAS $60.88
- Average True Range (ATR)
- CBSH 1.27
- EXAS 2.28
- MACD
- CBSH 0.00
- EXAS -0.14
- Stochastic Oscillator
- CBSH 85.20
- EXAS 10.81
About CBSH Commerce Bancshares Inc.
Commerce Bancshares Inc. is a $22 billion regional bank that provides a diversified line of financial services, including business and personal banking, wealth management, financial planning, and investments through its affiliated companies. Commerce Bank operates in more than 200 locations in the central United States. Commerce Bancshares also has operating subsidiaries involved in mortgage banking, leasing, credit-related insurance, venture capital, and real estate activities.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.